Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 16, 2022 08:30 ET | Source: Zylö Therapeutics

Zylö Receives $263,000 NIH Phase I Grant to Develop a Topical Viagra® for ED

Funds to be used to optimize a formulation and demonstrate comparable efficacy to oral Viagra GREENVILLE, SC, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., developer of the Z-pod®...
August 19, 2022 09:00 ET | Source: Zylö Therapeutics

Zylö Receives $600,000 NIH Phase I Grant to Develop a Novel Therapeutic to Treat Onychomycosis (Nail Fungus)

Funds to be used to optimize a formulation and prepare for scale-up and IND-enabling studies GREENVILLE, SC, Aug. 19, 2022 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., developer of the Z-pod®...
June 03, 2022 09:00 ET | Source: Zylö Therapeutics

Zylö Therapeutics Closes $5.225 Million Series B Financing

GREENVILLE, SC, June 03, 2022 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., dedicated to developing a transformational drug-delivery platform, announced that it has raised $5.225 million in its Series...
July 20, 2021 09:00 ET | Source: Zylö Therapeutics

Zylö Receives $1,700,000 NIH Phase II Grant to Advance Erectile Dysfunction Program into Human Trials

Funds to be used for scale-up, implementation of cGMP quality system, and pre-IND FDA meeting GREENVILLE, SC, July 20, 2021 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., developer of the...
July 28, 2020 10:00 ET | Source: Zylö Therapeutics

Zylö and Grapefruit Forge Partnership That Promises to Disrupt the Topical Cannabis Market

The Z-pod™ delivery system will help make Hourglass™ by Grapefruit a game-changer GREENVILLE, SC, July 28, 2020 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., developer of the transformational...